Celldex (CLDX) Tops Q4 EPS by 2c

Celldex (NASDAQ: CLDX) reported Q4 EPS of ($0.33), $0.02 better than the analyst estimate of ($0.35). Revenue for the quarter came in at $1.8 million versus the consensus estimate of $640 thousand.

For earnings history and earnings-related data on Celldex (CLDX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Barclays Starts DKSH Holding AG (DKSH:SW) at Overweight
• FirstCash to acquire UK pawn operator Ramsdens for £206 million